Loading
Sentiment · FY2026 Q2
UHS delivered Q1 adjusted EPS of $5.62 with 9.6% revenue growth as the Talkspace acquisition accelerated the outpatient behavioral continuum strategy, and full-year 2026 guidance was reiterated unchanged. Flu and weather created transitory volume drag in both segments, and the exchange subsidy headwind materialized as expected. AI deployment scaled with eight revenue cycle use cases live, and significant acute care capacity was coming online during 2026. Core growth of 5% was expected for the full year with acute same-facility revenue up 6.2% excluding health plan impacts.
Regulation Policy | Demand | Revenue Growth | Margin | Pricing | Competitive Dynamics | Guidance Reliability | Geographic Expansion | |
|---|---|---|---|---|---|---|---|---|
| 2024Q4 | 9 | 1 | 9 | 3 | 3 | 3 | 4 | 3 |
| 2025Q1 | 10 | 8 | 3 | 2 | 4 | 3 | 3 | 1 |
| 2025Q2 | 6 | 7 | 2 | 4 | 4 | 3 | 3 | 3 |
| 2025Q3 | 6 | 9 | 6 | 2 | 4 | 6 | 2 | 3 |
| 2025Q4 | 5 | 4 | 1 | 6 | 3 | 1 | 1 | 1 |
| 2026Q1 | 5 | 8 | 3 | 3 | 2 | 2 | 3 | 2 |
| '24Q4 | '25Q1 | '25Q2 | '25Q3 | '25Q4 | '26Q1 | |
|---|---|---|---|---|---|---|
| Regulation Policy | 9 | 10 | 6 | 6 | 5 | 5 |
| Demand | 1 | 8 | 7 | 9 | 4 | 8 |
| Revenue Growth | 9 | 3 | 2 | 6 | 1 | 3 |
| Margin | 3 | 2 | 4 | 2 | 6 | 3 |
| Pricing | 3 | 4 | 4 | 4 | 3 | 2 |
| Competitive Dynamics | 3 | 3 | 3 | 6 | 1 | 2 |
| Guidance Reliability | 4 | 3 | 3 | 2 | 1 | 3 |
| Geographic Expansion | 3 | 1 | 3 | 3 | 1 | 2 |
| Analyst | Firm | Questions (Challenge)Percentage of questions scored as challenging — where the analyst pushed back, pressed for specifics, or questioned management's assumptions. |
|---|---|---|
| A.J. Rice | UBS | 13 (0%) |
| Ben Rossi | JPMorgan | 13 (0%) |
| Matthew Gillmor | KeyBanc Capital Markets |
| Ryan Langston | TD Cowen | 11 (0%) |
| Craig Hettenbach | Morgan Stanley | 11 (0%) |
| Pito Chickering | Deutsche Bank | 10 (20%) |
| Jason Cassorla | Guggenheim | 10 (10%) |
| Andrew Mok | Barclays | 9 (22%) |
| Mike Ha | Robert W. Baird | 8 (0%) |
| Ben Hendrix | RBC Capital Markets | 7 (14%) |
| Firm | Analysts | Questions (Challenge)Percentage of questions scored as challenging — where the analyst pushed back, pressed for specifics, or questioned management's assumptions. |
|---|---|---|
| UBS | 1 | 13 (0%) |
| JPMorgan | 1 | 13 (0%) |
| TD Cowen | 1 | 11 (0%) |
| Morgan Stanley | 1 | 11 (0%) |
| KeyBanc Capital Markets | 1 | 11 (0%) |
| Guggenheim | 1 | 10 (10%) |
| Deutsche Bank | 1 | 10 (20%) |
| Bank of America | 2 | 9 (22%) |
| Quarter | Revenue | Rev YoY | EPS | EPS YoY | Op margin | Net margin | FCF |
|---|---|---|---|---|---|---|---|
| FY2024 Q4 | $4.11B | +11.1% | $4.96 | +57.0% | 11.5% | 8.1% | $412M |
| FY2025 Q1 | $4.10B | +6.7% | $4.80 | +25.7% | 11.1% | 7.7% | $121M |
| FY2025 Q2 | $4.28B | +9.6% | $5.43 | +27.5% | 11.7% | 8.2% | $283M |
| FY2025 Q3 | $4.50B | +13.4% | $5.86 | +54.2% | 11.6% | 8.3% | $133M |
| FY2025 Q4 | $4.49B | +9.1% | $7.01 | +41.3% | 11.5% | 9.9% | $293M |
| FY2026 Q1 | $4.50B | +9.6% | $5.65 | +17.7% | 11.2% | 7.8% | $184M |
| FY2026 Q2 | $4.64B | +8.3% | $5.98 | +10.1% | 11.1% | 7.7% | — |
Management’s own words, often on a non-GAAP, constant-currency, or adjusted basis — so these can differ from the GAAP figures above (e.g. constant-currency revenue growth excludes currency swings).
What UHS and other companies said about each other on FY2026 Q1 earnings calls — extracted verbatim from public transcripts. Mentions from the newest quarter are a Pro feature.
“several new use cases being designed and built with Hippocratic AI, which is one of our key AI solution partners.”
UHS is co-developing clinical AI use cases with Hippocratic AI, a key AI solution partner, for its 2026 hospital-efficiency roadmap.
“Talkspace is an established market leader in virtual outpatient behavioral health care with a network of 6,000 licensed professionals serving all 50 states.”
UHS is acquiring Talkspace to build an end-to-end behavioral health continuum, validating Talkspace's virtual platform and 6,000-clinician network as a strategic asset.
| Company | Score | Trend | Rev YoY |
|---|---|---|---|
UHS Universal Health Services | 7 | +9.7% | |
| DVA DaVita | 7 | +6.0% | |
| HCA HCA Healthcare | 6 | +4.3% | |
| SOLV Solventum | 6 | -3.0% |